Persistence of viral RNA, pneumocyte syncytia and thrombosis are hallmarks of advanced COVID-19 pathology | SARS-CoV-2 direct cardiac damage through spike-mediated cardiomyocyte 3 fusion | Prolonged infectious SARS-CoV-2 shedding from an asymptomatic immunocompromised cancer patient.
An inflammatory cytokine signature predicts COVID-19 severity and survival | Moderna phase III clinical study protocol | Pfizer phase III clinical study protocol | Identifying Optimal COVID-19 Testing Strategies for Schools and Businesses: Balancing Testing Frequency, Individual Test Technology, and Cost
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 | Rethinking Covid-19 Test Sensitivity — A Strategy for Containment | Adolescent with COVID-19 as the Source of an Outbreak at a 3-Week Family Gathering — Four States, June–July 2020 | Trends in COVID-19 Incidence After Implementation of Mitigation Measures — Arizona, January 22–August 7, 2020
Case-Control Study of Use of Personal Protective Measures and Risk for Severe Acute Respiratory Syndrome Coronavirus 2 Infection, Thailand | Characteristics and Maternal and Birth Outcomes of Hospitalized Pregnant Women with Laboratory-Confirmed COVID-19 — COVID-NET, 13 States, March 1–August 22, 2020 | Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia
Metformin Use Is Associated with Increased Incidence of Acidosis but not Mortality in Individuals with COVID-19 and Pre-existing Type 2 Diabetes | Rescission of Guidances and Other Informal Issuances Concerning Premarket Review of Laboratory Developed Tests | The Interpretation of SARS-CoV-2 Diagnostic Tests | Racial and Ethnic Disparities Among COVID-19 Cases in Workplace Outbreaks by Industry Sector
SARS-CoV-2 transmission at an overnight camp | Rapid Tests –
This website contains important information about rapid antigen testing for SARS-CoV-2. | In-Hospital Use of Statins Is Associated with a Reduced Risk of Mortality among Individuals with COVID-19 | Acute SARS-CoV-2 infection impairs DC and T cell responses